Trials / Completed
CompletedNCT02353234
Bioavailability of Phenolic Compounds in Bread
Bioavailability of Phenolic Compounds in Wholegrain Bread Compared With White Bread Enriched With Aleurone Fraction
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- University of Parma · Academic / Other
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
The consumption of wholemeal cereals has been associated with the reduction of several chronic diseases. The mechanisms behind these protective effects may be linked, besides dietary fiber and micronutrients, to an increased intake of phenolic compounds, mainly, hydroxycinnamates contained in the bran. Among bran fractions, aleurone usually contains the highest concentration of ferulic acid, principally contained as monomeric form and diferulic acid esters linked to arabinoxylans, representing the most relevant subclasses. The aim of the study was to evaluate the absorption of hydroxycinnamates by measuring the urinary excretion of phenolic metabolites in humans fed with two different kind of a commercial bread, as wholegrain bread and a white bread enriched with aleurone fraction. Moreover, the pharmacokinetics of the main phenolic compounds was also evaluated by measuring the circulating metabolites in plasma samples.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Bread | In each arm subjects consume bread |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2015-06-01
- Completion
- 2015-07-01
- First posted
- 2015-02-02
- Last updated
- 2015-12-02
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02353234. Inclusion in this directory is not an endorsement.